Cyclooxygenase-2 inhibitor decreases extracellular matrix synthesis in stretched renal fibroblasts

Nephron - Experimental Nephrology

Volumn 100, Issue 4, 2005, Pages

  El Chaar, Maher ^a   Attia, Erik ^c   Chen, Jie ^a   Hannafin, Jo ^b,c   Poppas, Dix P ^a   Felsen, Diane ^a,b  

^a Internal Medicine New York Presbyterian   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Cyclooxygenase 2; Extracellular matrix; Fibroblasts; Meloxicam; Protease; Stretch; TGF

Indexed keywords

COLLAGEN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; FIBRONECTIN; LAMININ; MELOXICAM; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL ELONGATION; CELL ISOLATION; COLORIMETRY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FIBROBLAST; IMMUNOFLUORESCENCE; IN VITRO STUDY; KIDNEY CELL; KIDNEY FIBROSIS; KIDNEY TUBULE PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; RAT; RAT STRAIN; SUPERNATANT; URETER OBSTRUCTION;

ANIMALS; CELL CULTURE TECHNIQUES; COLLAGEN; CYCLOOXYGENASE INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBROSIS; KIDNEY; PRESSURE; RATS; TENSILE STRENGTH; THIAZINES; THIAZOLES; TRANSFORMING GROWTH FACTOR BETA; URETERAL OBSTRUCTION;

EID: 21344470367     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085293     Document Type: Article

References (23)

1. Eddy AA: Molecular basis of renal fibrosis. Pediatr Nephrol 2000;15:290-301.
2. Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992;20:1-17.
3. Desmouliere A, Gabbiani G: Myofibroblast differentiation during fibrosis. Exp Nephrol 1995;3:134-139.
4. Gulmi FA, Felsen D, Vaughan ED Jr: Pathophysiology of Urinary Tract Obstruction; in Walsh P, Retik A, Vaughan ED Jr, Wein AJ (eds): Campbell's Urology. Philadelphia, Saunders, 2002.
5. Truong LD, Choi YJ, Tsao CC, Ayala G, Sheikh-Hamad D, Nassar G, Suki WN: Renal cell apoptosis in chronic obstructive uropathy: The roles of caspases. Kidney Int 2001;60:924-934.
6. 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 2000;58:1885-1892.
7. Miyajima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern J, Jha S, Pigato J, Lemer M, Poppas DP, Vaughan ED Jr, Felsen D: Antibody to transforming growth factor-β ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 2000;58:2301-2313.
8. 1 induced by angiotensin II and mechanical stretch in rat renal tubular epithelial cells. J Urol 2000;164:1729-1734.
9. Hegarty NJ, Watson RW, Young LS, O'Neill AJ, Brady HR, Fitzpatrick JM: Cytoprotective effects of nitrates in a cellular model of hydronephrosis. Kidney Int 2002;62:70-77.
10. Fung HB, Kirschenbaum HL: Selective cyclooxygenase-2 inhibitors for the treatment of arthritis. Clin Ther 1999;21:1131-1157.
11. Miyajima A, Ito K, Takako A, Seta K, Ueda A, Hayakawa M: Does COX-2 inhibitor prevent renal tissue damage in unilateral ureteral obstruction? J Urol 2001;166:1124-1129.
12. Gao X, Mae H, Ayabe N, Takai T, Oshima K, Hattori M, Ueki T, Fujimoto J, Tanizawa T: Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Kidney Int 2002;62:1238-1248.
13. Ogino K, Hatanaka K, Kawamura M, Katori M, Harada Y: Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1. Pharmacology 1997;55:44-53.
14. Wright EJ, McCaffrey TA, Robertson AP, Vaughan ED, Felsen D: Chronic unilateral ureteral obstruction is associated with interstitial fibrosis and tubular expression of transforming growth factor-β. Lab Invest 1996;74:528-537.
15. Hori Y, Katoh T, Hirakata M, Joki N, Kaname S, Fukagawa M, Okuda T, Ohashi H, Fujita T, Miyazono K, Kurokawa K: Anti-latent TGF-β binding protein-1 antibody or synthetic oligopeptides inhibit extracellular matrix expression induced by stretch in cultured rat mesangial cells. Kidney Int 1998;53:1616-1625.
16. Yasuda T, Kondo S, Homma T, Harris R: Regulation of extracellular matrix by mechanical stress in rat mesangial cells. J Clin Invest 1996;98:1991-2000.
17. Kim SG, Akaika T, Sasagaw T, Atomi Y, Kurosawa H: Gene expression of type I and type III collagen by mechanical stretch in anterior cruciate ligament cells. Cell Struct Funct 2002;27:139-144.
18. Blobe GC, Schiemann WP, Lodish HF: Role of transforming growth factor-β in human disease. N Engl J Med 2000;342:1350-1358.
19. Skutek M, Van Griensven M, Zeichen J, Brauer N, Bosch U: Cyclic mechanical stretching modulates secretion pattern of growth factors in human tendon fibroblasts. Eur J Appl Physiol 2001;86:48-52.
20. Tyagi SC, Lewis K, Pikes D, Marcello A, Mujumdar VS, Smiley LM, Moore CK: Metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells. J Cell Physiol 1998;176:374-382.
21. El Chaar M, Chen J, Stern JM, Seshan SV, Poppas DP, Vaughan ED Jr, Felsen D: Renal COX-2 in unilateral ureteral obstruction: Pattern of expression and role in interstitial fibrosis. J Urol 2005, in press.
22. Wang JL, Cheng HF, Shappell S, Harris RC: A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats. Kidney Int 2000;57:2334-2342.
23. Kato T, Ishiguro N, Iwata H, Kojima T, Ito T, Naruse K: Up-regulation of COX-2 expression by uni-axial cyclic stretch in human lung fibroblast cells. Biochem Biophys Res Commun 1998;244:615-619.